PubRank

Paolo Gionchetti

Author PubWeight™ 45.95‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis 2009 3.66
2 VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 2005 2.90
3 Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease. Gastroenterology 2011 2.21
4 Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol 2010 1.81
5 Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn's disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent. Eur J Radiol 2007 1.77
6 Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2012 1.71
7 Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 2003 1.51
8 European evidence-based Consensus on the management of ulcerative colitis: Special situations. J Crohns Colitis 2008 1.34
9 Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease. Gastroenterology 2007 1.24
10 Ileal pouchitis-related arthritis. Semin Arthritis Rheum 2002 1.23
11 Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis. Inflamm Bowel Dis 2010 1.11
12 Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study. Am J Gastroenterol 2005 1.11
13 Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression. Inflamm Bowel Dis 2005 1.06
14 Clinical guidelines for the management of pouchitis. Inflamm Bowel Dis 2009 1.06
15 Attachment and quality of life in patients with inflammatory bowel disease. Int J Colorectal Dis 2014 1.04
16 Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells. World J Gastroenterol 2006 1.02
17 European evidence based consensus on surgery for ulcerative colitis. J Crohns Colitis 2015 1.01
18 Adalimumab in active ulcerative colitis: a "real-life" observational study. Dig Liver Dis 2013 0.98
19 The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease. Dig Liver Dis 2010 0.95
20 Parental bonding and inflammatory bowel disease. Psychosomatics 2010 0.93
21 Adult attachment and early parental experiences in patients with Crohn's disease. Psychosomatics 2010 0.93
22 Effects of probiotic bacteria on gastrointestinal motility in guinea-pig isolated tissue. World J Gastroenterol 2006 0.93
23 Potential role for the common cystic fibrosis DeltaF508 mutation in Crohn's disease. Inflamm Bowel Dis 2007 0.91
24 Probiotic therapy to prevent pouchitis onset. Dis Colon Rectum 2005 0.90
25 Parvovirus b19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease. J Clin Microbiol 2009 0.83
26 Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. Intern Emerg Med 2011 0.82
27 Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing. Inflamm Bowel Dis 2010 0.81
28 Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls. J Behav Med 2012 0.81
29 Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis. World J Gastroenterol 2013 0.81
30 Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy. Dermatology 2007 0.81
31 Immunoregulatory activity of rifaximin associated with a resistant mutant of Bifidobacterium infantis. Int J Antimicrob Agents 2008 0.80
32 Systems biology approaches for inflammatory bowel disease: emphasis on gut microbial metabolism. Inflamm Bowel Dis 2014 0.80
33 Sympathetic hyperactivity in patients with ulcerative colitis. Clin Auton Res 2007 0.80
34 Clinical course of microscopic colitis in a single-center cohort study. J Crohns Colitis 2011 0.80
35 Antibiotics and probiotics in chronic pouchitis: a comparative proteomic approach. World J Gastroenterol 2010 0.79
36 Mucosal healing in pediatric Crohn's disease after anti-TNF therapy: a long-term experience at a single center. Eur J Gastroenterol Hepatol 2014 0.78
37 Infliximab in the treatment of Crohn's disease. Ther Clin Risk Manag 2007 0.78
38 CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue. Int J Colorectal Dis 2003 0.77
39 Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? Int J Colorectal Dis 2013 0.77
40 Rescue therapy: ciclosporin or infliximab? Expert Rev Clin Immunol 2013 0.75
41 Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease. World J Gastroenterol 2011 0.75
42 Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon. Nanomedicine 2012 0.75
43 Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease. Pathology 2014 0.75